These results, along with a previous report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assist the notion of targeting ACKR3 as a novel approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar disorders. “All round, the discovery of https://williamy813izd6.blogofchange.com/profile